It was described in the research literature as the first secretagogue of its kind that does not meaningfully raise cortisol or prolactin, even at doses far above what is needed to release growth hormone (Raun et al., 1998)
doi:10.1038/emm.2016.5 Bellini E, Grieco MP, Raposio E
Retatrutide weight-loss shot is still in clinical trials
Au bout de combien de temps les effets peuvent-ils tre observs
SELECT (NEJM 2023, n=17,604) showed a 20% MACE reduction with semaglutide in overweight and obese adults without T2D
Improves Energy Levels, Blood Flow, and Vessel Recruitment Studies have shown that BPC-157 helps reestablish the integrity of blood flow by improving blood vessel recruitment [3]